A Phase 2, Single Arm Study of Iniparib in Patients with BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Academic Article uri icon

Overview

MeSH Major

  • Benzamides
  • Carcinoma
  • Fallopian Tube Neoplasms
  • Ovarian Neoplasms
  • Peritoneal Neoplasms
  • Poly(ADP-ribose) Polymerase Inhibitors

abstract

  • Iniparib did not show significant activity in this heavily pretreated ovarian cancer population, all of whom had BRCA1 or BRCA2 mutations.

publication date

  • February 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5009457

Digital Object Identifier (DOI)

  • 10.1097/IGC.0000000000000591

PubMed ID

  • 26745694

Additional Document Info

start page

  • 255

end page

  • 60

volume

  • 26

number

  • 2